The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin.
During wound healing, migrating cells increase expression of both the vitronectin receptor (VNR) integrins and plasminogen activators. Here we report that vitronectin significantly enhances the migration of smooth muscle cells (SMCs), and that the specific VNR alpha V beta 3 is required for cell motility. We also show that the alpha V beta 3 attachment site on vitronectin overlaps with the binding site for plasminogen activator inhibitor (PAI)-1, and that the active conformation of PAI-1 blocks SMC migration. This effect requires high-affinity binding to vitronectin, and is not dependent on the ability of PAI-1 to inhibit plasminogen activators. Formation of a complex between PAI-1 and plasminogen activators results in loss of PAI-1 affinity for vitronectin and restores cell migration. These data demonstrate a direct link between plasminogen activators and integrin-mediated cell migration, and show that PAI-1 can control cell-matrix interactions by regulating the accessibility of specific cell-attachment sites. This indicates that the localization of plasminogen activators at sites of focal contact does not initiate a proteolytic cascade leading to generalized matrix destruction, but instead is required to expose cryptic cell-attachment sites necessary for SMC migration.
Stefansson
S
S
Biochemistry Department, J.H. Holland Laboratory, American Red Cross, Rockville, Maryland 20855, USA.
Lawrence
D A
DA
D000818:Animals; D002448:Cell Adhesion; D002465:Cell Movement / Q000502:physiology*; D066298:In Vitro Techniques; D009130:Muscle, Smooth / Q000166:cytology; D009154:Mutation; D009842:Oligopeptides / Q000378:metabolism; D017395:Plasminogen Activator Inhibitor 1 / Q000235:genetics / Q000378:metabolism*; D010960:Plasminogen Activators / Q000502:physiology*; D011485:Protein Binding; D011817:Rabbits; D019030:Receptors, Vitronectin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D015842:Serine Proteinase Inhibitors / Q000378:metabolism; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism; D019096:Vitronectin / Q000378:metabolism*; D014945:Wound Healing
D009842:Oligopeptides; D017395:Plasminogen Activator Inhibitor 1; D019030:Receptors, Vitronectin; D015842:Serine Proteinase Inhibitors; D019096:Vitronectin; C047981:arginyl-glycyl-aspartic acid; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator